l  General Information  | 
Product Name  | Cinacalcet HCl  | 
General description  | Cinacalcet Hydrochloride is the orally bioavailable hydrochloride salt of the calcimimetic cinacalcet.  | 
Synonym  | N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine;hydrochloride; AMG-073 HCl  | 
Purity  | ≥99.0%(HPLC)  | CAS Number  | 364782-34-3  | 
Formula  | C22H22F3N·HCl  | Molecular Weight  | 393.87  | 
Suitability  | BioReagent, suitable for cell culture, etc.  | 
l  Physical and Chemical Information  | 
Appearance  | Solid  | 
Solubility(25℃)  | DMSO  | ≥50mg/mL  | 
Ethanol  | ≥30mg/mL  | 
Water  | Insoluble  | 
l  Biological Information  | 
Biochem/Physiol
  Actions  | Cinacalcet Hydrochloride is the orally bioavailable hydrochloride salt of the calcimimetic cinacalcet. Cinacalcet increases the sensitivity of calcium-sensing receptors on chief cells in the parathyroid gland to extracellular calcium, thereby reducing parathyroid hormone (PTH) secretion. A reduction in PTH levels inhibits osteoclast activity, which may result in a decrease in cortical bone turnover and bone fibrosis, and normalization of serum calcium and phosphorus levels. In addition, by reducing PTH levels, cinacalcet may reduce PSA levels; PTH appears to raise PSA levels and may increase prostate cancer cell growth.  | 
l  Storage  | 
Storage temp.  | -20℃  | 
l  Precautions and Disclaimer  | 
This product is for R&D use only, not for drug, household, or other uses.  | 
l  References  | 
1.    http://www.drugbank.ca 2.    https://ncit.nci.nih.gov 3.    https://www.ncbi.nlm.nih.gov  |